• arclein
But this is unlikely to happen anytime soon, as there is currently no patent on DCA, and thus no incentive for private industry to research its potential benefits as a cancer treatment -- it's all about the money, after all, not public health. And governments are likely to ignore DCA as well, even though the medical research funds they disburse are intended for this very type of research, which is otherwise overlooked by the private sector in favor of more profi
Watch Streaming Broadcast Live:
LRN.fm
DLive
Live Chat Telegram
Share this page with your friends
on your favorite social network: